{[ promptMessage ]}

Bookmark it

{[ promptMessage ]}

bio- EC thalidomide

bio- EC thalidomide - Extra Credit Thalidomide In the 1960s...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Extra Credit: Thalidomide In the 1960s, Thalidomide caused an epidemic of phocomelia, the deformation or absence of limbs, in newborn children to mothers who used the German drug to quell their morning sickness. The sedative was never FDA approved but pregnant women in the US continued to use the drug. The incorrect isomer of the compound used in the medication caused catastrophic damage to the newborn infants. In adults, side affects resulted in irreversible numbing of the hands or feet. Now, clinical trials are being conducted to determine whether the drug Thalidomide can be used to treat a variety of diseases. They are testing its effectiveness on cancers, eye diseases, and AIDS. The drug has been found to obstruct the growth of new blood vessels, which would prove advantageous in macular degeneration (an overgrowth of new blood vessels in the center of the retina where focus is managed). The sedative has also been shown to encompass the ability of lowering TNF (Tumor Necrosis Factor, a chemical mediator in the body) Alpha levels. High TNF levels
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

{[ snackBarMessage ]}